Product NDC: | 61314-144 |
Proprietary Name: | Brimonidine Tartrate |
Non Proprietary Name: | Brimonidine Tartrate |
Active Ingredient(s): | 1.5 mg/mL & nbsp; Brimonidine Tartrate |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61314-144 |
Labeler Name: | Falcon Pharmaceuticals, Ltd. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021764 |
Marketing Category: | NDA |
Start Marketing Date: | 20101002 |
Package NDC: | 61314-144-10 |
Package Description: | 10 mL in 1 BOTTLE (61314-144-10) |
NDC Code | 61314-144-10 |
Proprietary Name | Brimonidine Tartrate |
Package Description | 10 mL in 1 BOTTLE (61314-144-10) |
Product NDC | 61314-144 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Brimonidine Tartrate |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 20101002 |
Marketing Category Name | NDA |
Labeler Name | Falcon Pharmaceuticals, Ltd. |
Substance Name | BRIMONIDINE TARTRATE |
Strength Number | 1.5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |